Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
British engineering company Smiths Group (SMIN.L) is in early-stage talks on a sale of its medical division which could raise more than 2 billion pounds ($3.04 billion), a source familiar with the situation said on Thursday. The firm began investigating a possible disposal after an approach from U.S. healthcare group CareFusion (CFN.N), the source said, confirming a report on the Financial Times website. There has been no decision to sell, nor any agreement on price, the source added. Smiths Group declined to comment when contacted by Reuters.
Help employers find you! Check out all the jobs and post your resume.
